Abstract Transient cerebral hypoperfusion (TCH) has empirically been used to assist intraarterial (IA) drug delivery to brain tumors. Transient (\3 min) reduction of cerebral blood flow (CBF) occurs during many neuro-and cardiovascular interventions and has recently been used to better target IA drugs to brain tumors. In the present experiments, we assessed whether the effectiveness of IA delivery of cationic liposomes could be improved by TCH. Cationic liposomes composed of 1:1 DOTAP:PC (dioleoyl-trimethylammoniumpropane:phosphatidylcholine) were administered to three groups of Sprague-Dawley rats. In the first group, we tested the effect of blood flow reduction on IA delivery of cationic liposomes. In the second group, we compared TCH-assisted IA liposomal delivery versus intravenous (IV) administration of the same dose. In the third group, we assessed retention of cationic liposomes in brain 4 h after TCH assisted delivery. The liposomes contained a near infrared dye, DilC 18 (7), whose concentration could be measured in vivo by diffuse reflectance spectroscopy. IA injections of cationic liposomes during TCH increased their delivery approximately fourfold compared to injections during normal blood flow. Optical pharmacokinetic measurements revealed that relative to IV injections, IA injection of cationic liposomes during TCH produced tissue concentrations that were 100-fold greater. The cationic liposomes were retained in the brain tissue 4 h after a single IA injection. There was no gross impairment of neurological functions in surviving animals. Transient reduction in CBF significantly increased IA delivery of cationic liposomes in the brain. High concentrations of liposomes could be delivered to brain tissue after IA injections with concurrent TCH while none could be detected after IV injection. IA-TCH injections were well tolerated and cationic liposomes were retained for at least 4 h after IA administration. These results should encourage development of cationic liposomal formulations of chemotherapeutic drugs and their IA delivery during TCH.
Introduction
A recent report describes temporary occlusion of the basilar to reduce blood flow so as to better control intraarterial (IA) bevacizumab delivery while treating brain tumors [1] . Similar techniques that reduce the blood flow have been used for IA treatment of liver and breast cancers [2] [3] [4] . However, advantages of reducing blood flow during IA injections go beyond the better control of drug delivery. Pharmacokinetic models suggest that IA drug delivery would be more effective when blood flow is reduced compared to normal blood flows [5, 6] . Experimental data show that transient reduction of cerebral blood flow (CBF) can increase non-liposomal drug delivery by 5-10-fold [7] [8] [9] . Pharmacokinetic models also show that IA delivery requires rapid extraction of drug during its first pass through the cerebral circulation. For maximum benefits of IA treatments, therefore, the reduction of blood flow has to be in conjunction with rapid uptake of the drug by the brain tissue.
In recent years liposomal formulations of drugs have emerged as vehicles to improve regional drug delivery but few study have investigated their IA applications. Intraarterial (IA) delivery of cationic liposomes is attractive because the positive surface charge of the liposomes will promote their retention by binding to the negatively charged vascular endothelial cells. For example, compared to intravenous (IV) delivery, IA administration of cationic magnetic nanoparticles results in 15-fold higher tissue drug concentrations [10] . Due to the non-specific uptake of cationic liposomes by the liver and spleen, and their binding to serum proteins that attenuates their surface charge, local delivery of cationic liposomes to the brain is limited after intravenous injections. The question arises whether transiently reducing blood flow could further improve the IA delivery of cationic liposomes.
The ultra-fast first-pass kinetics of IA drug injections are beyond the temporal resolution of conventional pharmacokinetic methods, such as micro-dialysis and tissue biopsy [11] . Therefore, we used a specialized version of diffuse reflectance spectroscopy (DRS) to track brain tissue concentrations of cationic liposomes that were labeled with a near infrared dye, DilC 18 (7) [12] [13] [14] . In this report we first determined the effect of flow reduction on the regional deposition of cationic liposomes. Having observed a clear increase in deposition, we compared the net benefit of such a method of drug delivery to traditional IV injections. Finally, to determine the safety of TCH assisted drug delivery and whether the increase in tissue concentrations of liposomes was sustained over time, we allowed the animals to recover from TCH assisted drug delivery and sacrificed them 4 h afterwards to assess tissue liposome concentrations.
Materials and methods
After approval by the institutional animal care and use committee, the three sets of experiments were conducted on Sprague-Dawley male rats weighing 200-300 g. Under anesthesia with intramuscular ketamine, supplemented with IV propofol and/or inhaled isoflurane, surgical preparation included the following: placement of a 24G tail vein cannula; tracheostomy (group 1 and 2) or an endotracheal intubation (group 3) for mechanical ventilation using a small animal ventilator (Harvard Apparatus, Holliston, MA); right femoral arterial cannulation (P-10 PTFE) and right common carotid cannulation (also P-10 PTFE); and the internal carotid artery (ICA) isolation by ligating external carotid branches. Arterial lines were flushed with de-aired heparin saline (1 unit/ml). Through a mid-line incision, the skull was exposed. The right parietal bone was thinned such that the cortical arteries and veins could be seen distinctly through the inner table and was used for monitoring brain tissue liposome concentrations. The right frontal bone was also thinned for placement of a laser Doppler probe. EKG and end-tidal gas composition were monitored continuously. A pulse oximeter was placed over the right forepaw. Esophageal and rectal probes monitored the animal's core temperature.
ICA isolation
Because of anatomical variations of the carotid system, a careful isolation of the ICA is necessary for obtaining consistent results from IA drug delivery experiments. The dissection was done by an experienced operator (MW) who first identified the vessel by its anatomy, and subsequently by the retinal discoloration test, which gives blanching of the retina upon injection of a 0.1 ml of saline bolus [15] .
Diffuse reflectance spectroscopy (DRS)
Changes in back-scattered light from tissue after an injection of a chromophore can be assessed by DRS. Bigio et al. [16] have described the underlying physics of the method in earlier publications [13, 14, 16, 17] . DRS measurements were made with a custom-built system (Optimum Technology Inc., Boston MA). A fiber optic probe, with specified separation between the emitting and collecting fibers, enabled extraction of absolute chromophore concentrations by the optical pharmacokinetic method [13, 14] . A depth of *2-4 mm of brain tissue can be interrogated with this optical geometry, and a measurement takes less than 0.5 s. These measurements can be undertaken through the inner table of the thinned skull. A total of 612 spectra over a period of approximately 30 min were obtained from the brain tissue for each injection in order to generate a concentration-time curve.
Multispectral imaging (MSI)
Surface fluorescence images of postmortem tissues were acquired by a custom built spectral imaging system similar to that described in Bouchard et al. [18] . Excitation of the extracted whole brain utilized a 735 nm LED equipped with a 740 nm band-pass filter (Thorlabs, Newton, NJ). A 750 nm long-pass dichroic mirror was used to couple the optical paths of the light source and imager and allow fairly even illumination over field of view (Edmund Optics, Barrington, NJ). Fluorescence images were acquired by a CCD camera with a 780 ± 10 nm band-pass filter was mounted onto the lens. Image acquisition was automated by a microcontroller programmed with a custom C program that synchronized camera integration time with the LED strobe illumination settings. Matlab (MathWorks, Natick, MA) was used for analysis of the fluorescence images.
Postmortem measurements of liposome concentration in brain tissue
In survival studies investigating longer-term liposome deposition, in vivo DRS measurements were not possible to minimize trauma to the animals. We therefore used MSI in conjunction with DRS to determine tissue concentrations postmortem at the desired sampling time. The baseline was usually obtained from the contralateral middle-or posterior cerebral arterial distribution, which has minimal liposome exposure during IA injection. The acquired DRS spectra were normalized by the intensity at 800 nm. The concentrations of liposomes were determined by DRS in the ipsilateral and contralateral hemispheres, and in the regions of distribution of the anterior-, middle-, and posterior cerebral arteries (Fig. 3 ).
Micro-pulse injection
For IA injection, a total volume of 1 ml of liposomes was injected as micro-boluses of approximately 67 ll administered at 3-s intervals using an electronically controlled pneumatic syringe system. A signal generator (33220A, Agilent Technologies Inc. Santa Clara, CA) was used to trigger the solenoid on a pressure ejector (Picospritzer III, Parker Hannifin, Pine Brook, NJ), permitting reproducible pulses of compressed air (20 PSI) to drive the plunger of the attached syringe.
Transient cerebral hypoperfusion (TCH)
To maximize IA drug delivery, CBF was decreased transiently during liposome injection. TCH was achieved by IV bolus injection via the tail vein of adenosine (2 mg) and esmolol (2 mg) followed by a saline flush and concurrent contralateral arterial occlusion, as needed. In rats, this produces TCH the duration of TCH can be greatly increased if the animal is rendered hypothermic (30-32°C). In the IA injection regimen, the contralateral arterial occlusion was released after drug injection, and in the hypothermic group, warming was started soon after drug injection. However, hypothermia alters mean arterial pressures, reduces CBF, and delays recovery from anesthesia. Therefore, in the second and third groups of animals, TCH was induced by flushing 2.5 ml of cold saline (4°C) via the tail vein catheter following the administration of the hypotensive drugs. In normothermic animals (group 2 and 3), TCH lasts 2-5 min and reverses spontaneously ( Fig. 1) .
Liposome preparation
The source of reagents were: dimyristoylphosphatidylcholine (DMPC) and dioleoyl-trimethylammonium-propane (DOTAP): Avanti Polar Lipids (Alabaster, AL); DiIC 18 (7) dialkyl carbocyanine membrane label (DiR): Invitrogen (Carlsbad, CA); cholesterol (Chol): Sigma-Aldrich (St. Louis, MO).
The liposomes were prepared by hydration of a dried lipid film followed by extrusion to produce a uniform size distribution. Briefly, DMPC:DOTAP:Chol:DiIC 18 (7) in molar ratios of 2.75:2.75:4.5:1.1 were mixed in chloroform and dried under vacuum. The resulting lipid film was hydrated to a concentration of 20 mM in NaCl/Tris (150 mM NaCl, 25 mM TRIS, pH 7.0) with vigorous vortexing. After 5 freeze-thaw cycles, the preparation was extruded stepwise through polycarbonate filters of decreasing pore size to a final diameter of 80 nm. The final phospholipid concentration was quantified by phosphorous assay [19] , and the preparation was diluted in NaCl/Tris to a concentration of 10 lmol of diacyl lipid (DO-TAP ? DMPC) per ml. Prior to injection, 0.6 ml of the liposomes were diluted in NaCl/Tris buffer to a volume of 1 ml.
Data acquisition and statistical analysis
The hemodynamic data were recorded in real-time (200 Hz) on a Power Lab data acquisition system (AD Instruments Inc., Colorado Springs, CO). Data were analyzed at: (a) baseline before injection of liposomes, (b) at the peak concentration after injection, (c) 5 min after injection, and (d) 30 min after injection. The total exposure to cationic liposomes was determined as the sum of the area under the concentration-time curve (AUC). For group 1 animals, the AUC was further divided into injection and clearance phases. Data were analyzed by ANOVA for repeated measures, and ANOVA factorial as post hoc correction was used for multiple comparisons. Statistical Analysis was done using the Stat View 5.2 program (SAS Institute, Cary, NC).
Results
Three experiments were conducted on a total of 30 male Sprague-Dawley rats. These experiments were aimed to: (i) investigate the effect of TCH during IA injection upon the tissue deposition of cationic liposomes; (ii) compare TCH-assisted IA drug delivery versus conventional IV delivery of cationic liposomes; and (iii) investigate whether liposome deposition in brain following TCH-assisted IA delivery persists over longer time periods.
Effect of TCH on the IA delivery of cationic liposomes Eleven animals were randomized into two treatment arms: 5 with normal CBF and 6 with TCH. In this initial experiment, the core temperature was different between the two groups because systemic hypothermia was used to achieve a reproducible TCH by inducing transient cardiac arrest (30.1 ± 1.6°C ± vs. 36.5 ± 2.1°C). As expected, physiological differences were evident between the two groups due to the background hypothermia ( Table 1) . Injection of liposomes during TCH increased tissue deposition. Peak liposome concentrations were significantly higher when administered with TCH compared to normal blood flow, 1.32 ± 0.51 versus 0.72 ± 0.28 lM, respectively, P \ 0.05. End concentrations were 0.43 ± 0.17 lM for TCH versus 0.11 ± 0.06 lM for normal blood flow, P \ 0.005, and total area under the concentration-time curve was considerably higher for the TCH group, Table 1 ; Fig. 2 . Direct comparison between TCH-assisted IA drug delivery and conventional IV delivery
In this experiment, a modified method was used to decrease the CBF: adenosine and esmolol were administered and then flushed with cold saline to induce mild hypothermia. The IV injection of cationic liposomes had no significant hemodynamic effect the hemodynamic and blood flow parameters remained stable during IV injections. With TCH assisted IA delivery, CBF decreased and subsequently returned rapidly to baseline after injection. The observed brain concentration of liposomes after IA injection registered a clear peak that coincided with the end of the injection, whereas there was no distinct peak with IV injections. Liposome concentrations in the brain were barely detected after IV injection. The peak value of liposome deposition with flow-arrest IA delivery was 30-fold higher than observed following IV injection, and the end-value concentration of liposomes was 100 fold greater in the flow-arrest IA delivery group (Table 2 ; Fig. 2 ). However, low concentration of liposomes after IV injection generated subtle spectral changes more susceptible to noise, which may have affected DRS curve fitting results.
Longer-term retention of cationic liposomes
The objective of this group was to assess the safety of flow arrest drug delivery and to determine whether cationic liposomes were retained for extended time periods. Seven of nine animals completed the survival protocol; two animals were lost due to bleeding from the carotid stump after catheter removal: one was sacrificed at 1 h and the other at 2 h after liposome injection. The data from these animals was excluded from analysis and is presented separately. At 4 h, the remaining seven animals had recovered from anesthesia, and were spontaneously active in their cages, with no evidence of any gross neurological impairment. Although fewer hemodynamic parameters were monitored during IA administration so as to minimize trauma, the hemodynamic changes in this group were similar to those observed in non-survival experiments: a significant decrease in heart rate, end-tidal CO 2 , and skin blood flow during injection (Table 3) , all of which recovered rapidly after the administration protocol. With postmortem multispectral imaging of the extracted brain, retention of liposomes was clearly evident in the hemisphere of drug infusion 4 h after administration (Fig. 3) . Quantification of regional concentrations of liposomes by DRS, guided by multispectral imaging, is shown in Figs. 3 and 4 .
Discussion
Reduction of CBF to assist IA drug delivery is different for brain as compared to other organs [2, 3] . The benefits of such interventions have to be balanced against the potential risk of stroke. The high resting blood flow of the brain tissue can diminish the efficacy of IA injections. It decreases peak concentrations, reduces tissue drug transit time, and increases drug washout. A reduction in bolus volume below 20 % of the background blood flow can lead to regional variations in downstream drug concentrations due to streaming [20] [21] [22] . Better targeting of drugs has led to the clinical use of arterial occlusion for treating brain tumors in human subjects [1] . While reducing blood flow can enhance the efficacy of IA drugs, their full impact will only be evident if there was rapid uptake of the drug during its first pass through the cerebral circulation [3, 5] . Therefore, there is a need to for optimal selection and formulation of IA drugs prior to clinical use. Here we investigated whether transient reduction of CBF during IA injection would increase regional deposition of cationic liposomes, which show high extraction efficiencies in brain compared to uncharged or anionic liposomes [23] . The results suggest that uptake is increased approximately three-fold when IA injections are made during TCH compared to injections made during normal blood flow. Optical pharmacokinetic measurements revealed that the peak concentrations achieved by IA injection during cerebral hypoperfusion were 30 fold higher than those achieved by injection of the same dose IV. In addition, the end concentrations of cationic liposomes retained in the brain 30 min after injection were 100-fold higher for IA delivery compared to IV delivery. Furthermore cationic liposomes were retained by the brain tissue 4 h after a single injection. The concept of regional delivery of drugs by the IA route has been pursued with varying degrees of vigor over the last half century [1, 5, 24] . Although an attractive idea, IA drug delivery has not found widespread clinical application for brain tumor treatments [2, 3, 11] . A fundamental challenge to IA drug delivery is that drugs must be extracted efficiently as they transit rapidly through a very well perfused tissue. The high CBF dilutes the injected drugs, decreases the transit time, thereby limiting contact with the endothelial cell surfaces, and washes out much of the drug that distributed into the tissue when peak concentrations were achieved. For effective uptake, drugs must be rapidly absorbed and tightly retained by the brain tissue during the short transit time through the cerebral circulation.
Drugs and drug formulations are seldom developed or screened for the IA delivery route, and thus seldom have the physicochemical characteristics necessary for efficient delivery. The results of this study that show improved regional drug deposition of cationic liposomes with IA injections, that is further enhanced delivery during TCH, are consistent with observations in other investigations. IA injection of BCNU achieves 50 fold higher concentrations in human subjects than achieved by systemic IV injections, based on positron emission tomography [25] . In rabbits subjected to IA injection of BCNU during TCH, we observed a 24-fold increase in brain tissue concentrations after 5 min, compared to IV injection [7] . Indirect measurement of tissue concentrations, such as by the duration of electro-cerebral silence after intracarotid injection of anesthetic drugs, similarly suggest a five-to ten-fold increase in dose effects when injected IA during TCH. The relevant observation here is that not only was there an enormous increase in tissue liposomal deposition after TCH assisted IA delivery, significant retention of cationic liposomes in the brain was observed for up to 4 h after injection.
Manipulation of blood flow is seldom utilized as a means enhance drug delivery. However, in conjunction with IA delivery, bolus injection of drugs during TCH is both feasible and beneficial for several reasons: IA injection achieves higher peak arterial blood concentrations, and minimizes protein binding and uptake by blood elements that reduce deposition in the target tissue; TCH increases transit time to facilitate tissue uptake, and decreases blood clearance. Under normal circumstances, brain tissue can tolerate several minutes of cerebral ischemia, which can be extended further with hypothermia Transient blood flow reduction is often used in neurovascular surgery such as in clipping of aneurysms, endovascular procedures such as during balloon test occlusion, embolization of high flow cerebral arteriovenous malformations, and deployment of stents. At our center adenosine was used to transiently arrest CBF in human subjects for treating high flow cerebral arteriovenous malformations [26] [27] [28] . However, small-balloon tipped microcatheters can circumvent the need for systemic arrest. Such microcatheters can reduce blood flow locally while permitting drug injections in a small region of interest as shown recently by Riina et al. [1] for human glioma treatments. In 2004, Yamane et al. [4] used balloon occlusion of the supra-ophthalmic internal carotid artery in 187 pediatric patients during 563 procedures for super-selective IA delivery of chemotherapeutic drugs for retinoblastoma treatment. The only reported complication was bradycardia during injection. Thus, a reasonable case can be made for employing TCH to augment drug delivery in the treatment of fatal brain diseases such as malignant brain tumors.
We have not yet evaluated the flow arrest IA delivery of the liposomes in experimental tumor models but we can forsee additional considerations in delivering them to brain tumors [29] . For example, tumor blood vessels have greater permeability that will increase liposomal extravasation. However, the tumor stroma might restrict diffusion, particularly of larger liposomes. To optimize IV liposomal delivery to tumors, liposomes are protected with poly- ethylene glycol that decreases their uptake by reticuloendothelial cells so as to increase their circulating half lives. As a result of their extended life, the particles are preferentially taken up by tumors due to a more permeable tumor-blood barrier compared to normal tissues [30] . However, with IA delivery such protection is not needed as the particles will avoid contact with blood cells and interact directly with the endothelium. The retention of liposomes over 4 h in the present study suggests that cationic liposomes are likely to be retained by tumors as well. However, as with any other nanoparticle, size of liposome will critical to diffusion across the blood tumor barrier and within the tumor stroma.
Conclusion
In summary, this study highlights two things. First, it highlights the approach to optimizing liposome delivery by using optical tracers as drug surrogates to permit high speed measurements by DRS, supported by postmortem multispectral imaging. Second, it highlights the value of TCH assisted IA pulse injections of cationic liposomes for brain drug delivery. TCH was well tolerated by the animals and cationic liposomes were retained for at least 4 h after IA administration. These results should encourage development of chemotherapeutic drug containing cationic liposomes and their IA delivery during TCH.
